A significant medical achievement was recorded at Sultan Qaboos University Hospital in the management of acute poisoning. A ...

QTX-2101 is an investigational, oral arsenic trioxide therapy that has not yet been approved by any regulatory authority. Its safety and efficacy are currently under evaluation. This press release ...

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

During the opioid crisis in the United States, acute pain management has remained a persistent challenge for both patients and clinicians.

On behalf of IQWiG, a scientific team led by the University of Freiburg has investigated whether shorter-duration antibiotic therapy yields treatment ...

For pediatric nonoperative fractures and sprains, adding acetaminophen or hydromorphone to ibuprofen does not provide better ...

Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease progression and showed sustained benefit in ...

Chemotherapy for pediatric acute lymphoblastic leukemia (ALL) induces rapid and durable alterations in cerebrospinal fluid (CSF) metabolism, and a lipid-rich CSF signature measured early in treatment ...

Manual therapy — joint mobilization and soft-tissue techniques—adds critical short-term benefits. Studies demonstrate that ...

USA: Researchers have found in a new study that in adults with acute and subacute low back pain, a biopsychosocial-oriented ...

After a spate of patient deaths in 2025 linked to the company’s Duchenne gene therapy, Sarepta shared new data showing benefits of the therapy three years after dosing.